BANK VONTOBEL/CALL/STRYKER CORP./360/0.1/20.09.24 Stock

Warrant

DE000VM8UXY1

Market Closed - Deutsche Boerse AG 01:42:13 2024-06-28 pm EDT
0.64 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./360/0.1/20.09.24
Current month-21.95%
1 month-13.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 0.64 0.00%
24-06-27 0.64 +4.92%
24-06-26 0.61 +10.91%
24-06-25 0.55 -22.54%
24-06-24 0.71 +5.97%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 01:42 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM8UXY
ISINDE000VM8UXY1
Date issued 2024-01-19
Strike 360 $
Maturity 2024-09-20 (83 Days)
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.65
Lowest since issue 0.43
Spread 0.03
Spread %4.35%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus